Navigation Links
InterMune in Medical News

Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations

SAN FRANCISCO, March 18 /PRNewswire-USNewswire/ -- W. Scott Harkonen, M.D., the former CEO of InterMune Inc., was indicted on wire fraud and felony Food, Drug and Cosmetic Act charges for his role in the creation and dissemination of false and misleading information about the efficacy of Inter...

New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report

...d Tripep Release Additional Interim Results for ChronVac-C(R) II-56 intermune Starts Clinical Study of ITMN-191 II-57 Roche and Associates Commence C... and Ortho-Clinical II-66 Peregrine Opens Subsidiary in China II-66 intermune Completes Production Milestone II-66 Arrow Expands Hepatitis C Pipeline...

Important Data Presented on Independent Predictors of Mortality in Patients With Idiopathic Pulmonary Fibrosis

...uch an index." About the CAPACITY Program intermune has reported the results of two concurrent, random...ported in the du Bois presentation at ATS. intermune expects to submit a new drug application (NDA) to ... rash and gastrointestinal symptoms. About intermune ...

InterMune to Present at Cowen Health Care Conference

...er or download any necessary software. About intermune intermune is a biotechnology company focused on the research...novative therapies in pulmonology and hepatology. intermune has a pipeline portfolio addressing idiopathic pul...

InterMune Reports Results from Triple Combination Study of ITMN-191

...Chairman, Chief Executive Officer and President of intermune said, "We are very pleased to report that in this ...All-oral STAT-C study) In November 2008, Roche, intermune and Pharmasset initiated the first all-oral combin...ar. Conference Call and Webcast Details intermune will host a conference call today at 8:30 a.m. EST...

InterMune to Present at Thomas Weisel Partners Healthcare Conference

...wnload any necessary software. About InterMune intermune is a biotechnology company focused on the research...nnovative therapies in pulmonology and hepatology. intermune has a research and development portfolio addressin...et in hepatology. For additional information about intermune and its R&D pipeline, please visit http://www.int...

InterMune to Present at the 2008 Wachovia Healthcare Conference

...wnload any necessary software. About InterMune intermune is a biotechnology company focused on the research...nnovative therapies in pulmonology and hepatology. intermune has a pipeline portfolio addressing idiopathic pul...et in hepatology. For additional information about intermune and its R&D pipeline, please visit http://www.int...

Manufacturer to Pay $20 Million for Improperly Promoting a Sleep Disorder Drug

...l scrutiny recently for their drug marketing practices. In October, intermune of Brisbane agreed to pay $36.9 million to settle federal charges it engage...ting a bone disorder and a condition that makes people prone to infections, intermune was accused of improperly promoting it to treat a fatal lung disease. ...
InterMune in Medical Technology

Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C

PRINCETON, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS ), Roche (SWX: ROG) and InterMune, Inc. (Nasdaq: ITMN ) today announced that the first patients have been dosed in an innovative clinical trial in patients chronically infected with the hepatitis C virus (HCV)....

Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)

...enerally well tolerated in both CAPACITY studies. intermune is preparing a New Drug Application (NDA) expected...To better understand the primary efficacy outcome, intermune conducted an exploratory analysis that interrogate...for the treatment of IPF. Webcast Details intermune will host a teleconference and webcast, with accom...

Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen

...loped by other companies. The collaborations with intermune and Pharmasset position Roche as a leader in devel... for HCV. Dial-In and Webcast Details intermune and Pharmasset will host a live webcast of a discu...INFORM-1 trial. Members of management from Roche, intermune and Pharmasset will also be available to answer qu...

Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C

...els of HCV(<15 IU/ml) after 4 weeks, compared to 60 percent in the standard of care arm. In November 2008, Roche, Pharmasset and intermune initiated the INFORM-1 trial to investigate the combination of R7128 with InterMune's R7227, a protease inhibitor, in HCV patients. This is the first-...

InterMune Reports Presentation of Triple Combination Study of ITMN-191 at European Association for the Study of the Liver (EASL)

...file of ITMN-191 observed will be confirmed." intermune noted that a Phase 2b triple combination trial of ... INFORM-1 Program In November 2008, Roche, intermune and Pharmasset initiated the first all-oral combin...meeting on Saturday, April 25, 2009. About intermune ...

InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3

...IPF) prior to market open on Tuesday, February 3. intermune will conduct a conference call and webcast, with a...ntering the conference ID# 84164912. About intermune intermune is a biotechnology company focused on the research...

InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191

...ntering the conference ID# 80676348. About intermune intermune is a biotechnology company focused on the research...et in hepatology. For additional information about intermune and its R&D pipeline, please visit htpp:// www...

InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009

...ng with a total daily dose of 300mg. About intermune intermune is a biotechnology company focused on the research...s in hepatology. For additional information about intermune and its R&D pipeline, please visit http://www...

InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C

...ic hepatitis C virus (HCV) genotype 1 infection. intermune also reported that results from the only cohort of... ITMN-191 when given with Pegasys and ribavirin. intermune expects to announce top-line results from the trip...r of this year. Publication Plans for ITMN-191 intermune intends to submit several abstracts regarding ITMN...

InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA

...ast and Conference Call on May 20, 5:00 p.m. EDT intermune additionally announced that it will conduct a live...wnload any necessary software. About InterMune intermune is a biotechnology company focused on the research...nnovative therapies in pulmonology and hepatology. intermune has a research and development portfolio addressin...
InterMune in Biological Technology

Evotec Expands Collaboration With InterMune

Fragment-Based Drug Discovery Program Yields Results and Leads to Expansion of Collaboration HAMBURG, Germany and OXFORD, England, March 6 /PRNewswire-FirstCall/ -- Evotec AG (Frankfurt Stock Exchange: EVT) today announced that InterMune, Inc., has signed a second drug...

InterMune to Present at Canaccord Adams Conference

... or download any necessary software. About intermune intermune is a biotechnology company focused on the research...novative therapies in pulmonology and hepatology. intermune has an R&D portfolio addressing idiopathic pul...

InterMune Reports Second Quarter 2009 Financial Results and Business Highlights

...ond quarter and six months ended June 30, 2009. intermune reported a net loss for the second quarter of 2009...eral months have been exceptionally productive for intermune and the coming months promise to be even more so. ...esults for the Three Months Ended June 30, 2009 intermune reported total revenue in the second quarter of 20...

InterMune to Release Second Quarter Financial Results on August 6

...live conference call and webcast will be hosted by intermune at 4:30 p.m. Eastern time that same day. To...ntering the conference ID# 22196018. About intermune intermune is a biotechnology company focused on the research...

InterMune to Present at Goldman Sachs Healthcare Conference

...er or download any necessary software. About intermune intermune is a biotechnology company focused on the research...novative therapies in pulmonology and hepatology. intermune has a pipeline portfolio addressing idiopathic pul...

Results From Phase 3 CAPACITY Program of Pirfenidone in IPF and Study of Predictors of Mortality in IPF to be Presented at ATS

...HE CAPACITY TRIALS) Webcast Details intermune will host a teleconference and webcast on Tuesday,... entering the conference ID# 97738057. About intermune intermune is a biotechnology company focused on the research...

Pharmasset Reports Fiscal Second Quarter 2009 Financial Results

...lion, or $0.57 per share for the quarter ended March 31, 2008. Recent Highlights: On April 25, 2009, Pharmasset, Roche, and intermune reported results from the INFORM-1 trial as an oral late breaker at the European Association for the Study of the Liver (EASL) in Copenhagen, Denmark....

InterMune Reports First Quarter 2009 Financial Results and Business Highlights

...ons for the first quarter ended March 31, 2009. intermune reported a net loss for the first quarter of 2009 ... to sharing those results as they develop." intermune reported total revenue in the first quarter of 200...tions of Actimmune for the treatment of IPF, which intermune does not promote. Research and development ...

INFORM-1 Clinical Trial Amended to Further Explore Promising Direct Antiviral Regimen in HCV Patients

...tract can be viewed at www.easl.ch About intermune intermune is a biotechnology company focused on the research...novative therapies in pulmonology and hepatology. intermune has an R&D portfolio addressing idiopathic pul...

InterMune to Release First Quarter Financial Results on April 30

...live conference call and webcast will be hosted by intermune at 4:30 p.m. Eastern time that same day. To ... entering the conference ID# 95970767. About intermune intermune is a biotechnology company focused on the research...
Other Tags
(Date:7/30/2015)... , ... July 30, 2015 , ... OSF Healthcare ... results from the 2015 Most Wired Survey conducted by Hospitals & Health Networks. This ... system owned and operated by The Sisters of the Third Order of St. ...
(Date:7/30/2015)... ... July 30, 2015 , ... The connection between a healthy head of hair and a ... of a full head of hair can have a devastating impact on the daily life ... in the work place, the consequences of hair loss are not to be taken lightly. ...
(Date:7/30/2015)... York, NY (PRWEB) , ... July 30, 2015 ... ... Setria®Glutathione and Sustamine® L-Alanyl-L-Glutamine for people on the go. With no water needed, ... Recovery Chewable as a simple way to get the natural ingredients that may ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... worked to protect victims in San Diego, California’s Gaslamp Quarter Plaza for five ... Gaslamp Quarter Plaza actively monitor the area for any suspicious activity. These cameras ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... ... scientific program at ATA’s 21st Annual Meeting and Tradeshow focused exclusively on telemedicine, ... than 300 cutting-edge health care technology vendors, will take place May 14-17, 2016 ...
Breaking Medicine News(10 mins):Health News:OSF HealthCare Named One of the Most Wired Systems 2Health News:OSF HealthCare Named One of the Most Wired Systems 3Health News:New Study Shows the Link between Hair Restoration and Healthy Self-Image 2Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 2Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 3Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 4Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 2Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 3Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 2Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 3
(Date:7/8/2015)... -- The consumer products industry for innovative tech ... such as wearables, smart wallets & other smart technology are ... continues to rapidly grow.  Biometrics & Wearable Device Companies in ... Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: AAPL ... GPRO ) and Baidu Inc. (NASDAQ: BIDU ) ...
(Date:7/7/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... commerce market announces a revised version of one of its first ... air on CNBC in New York , ... San Francisco metro areas.    ... ability to replace all the cards in your wallet and keep ...
(Date:7/2/2015)... 2015 Fingerprint Cards has received an ... FPC1155 from the distributor World Peace Industrial Group (WPI), part ... Asia . Deliveries are planned to take ... used by smartphone manufacturers in Asia . ... communicated revenue guidance of approximately 2,200 MSEK for 2015. ...
Breaking Biology News(10 mins):Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 2Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 4Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 5Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 6Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2
Other Contents